Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP778693.RARFslh4TuMmfwRkzxVqd7Zi6Nhx9m8yhCKuZDbWafEbA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP778693.RARFslh4TuMmfwRkzxVqd7Zi6Nhx9m8yhCKuZDbWafEbA130_assertion type Assertion NP778693.RARFslh4TuMmfwRkzxVqd7Zi6Nhx9m8yhCKuZDbWafEbA130_head.
- NP778693.RARFslh4TuMmfwRkzxVqd7Zi6Nhx9m8yhCKuZDbWafEbA130_assertion description "[Moreover, GATA5 CGI methylation could serve as a biomarker for tumour progression, although prospective and functional investigations are necessary to clarify whether independent information for future clinical management of patients with RCC can be obtained.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP778693.RARFslh4TuMmfwRkzxVqd7Zi6Nhx9m8yhCKuZDbWafEbA130_provenance.
- NP778693.RARFslh4TuMmfwRkzxVqd7Zi6Nhx9m8yhCKuZDbWafEbA130_assertion evidence source_evidence_literature NP778693.RARFslh4TuMmfwRkzxVqd7Zi6Nhx9m8yhCKuZDbWafEbA130_provenance.
- NP778693.RARFslh4TuMmfwRkzxVqd7Zi6Nhx9m8yhCKuZDbWafEbA130_assertion SIO_000772 22289415 NP778693.RARFslh4TuMmfwRkzxVqd7Zi6Nhx9m8yhCKuZDbWafEbA130_provenance.
- NP778693.RARFslh4TuMmfwRkzxVqd7Zi6Nhx9m8yhCKuZDbWafEbA130_assertion wasDerivedFrom befree-20140225 NP778693.RARFslh4TuMmfwRkzxVqd7Zi6Nhx9m8yhCKuZDbWafEbA130_provenance.
- NP778693.RARFslh4TuMmfwRkzxVqd7Zi6Nhx9m8yhCKuZDbWafEbA130_assertion wasGeneratedBy ECO_0000203 NP778693.RARFslh4TuMmfwRkzxVqd7Zi6Nhx9m8yhCKuZDbWafEbA130_provenance.